Search

everythinglearnresearchcommunity

for

Search:↓

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

COVID-19 infection is linked to temporary hair loss in Egyptian women.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Topical Minoxidil is effective for hair loss after COVID-19.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Hair loss can occur about 4 weeks after scalp surgery but usually grows back within 3 months without treatment.

The document suggests that hair loss after stopping birth control may be similar to post-pregnancy hair loss and could recur with future pregnancies.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Poor nutrition is linked to increased hair loss in Canadian children.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Hair casts may be a useful clue for diagnosing hair loss during the resting phase of hair growth.

Iron deficiency anemia is significantly linked to hair loss in childbearing women, and taking iron improves the condition.

Women with telogen effluvium have an imbalance in thiol-disulphide, suggesting oxidative stress may contribute to hair loss.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

More atypical club hairs may indicate Telogen Effluvium.

COVID-19 may cause temporary hair loss due to the body's immune response.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 has increased hair loss, but many patients see regrowth within months.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.